Repatha

Medicines Company Rallies On Positive LDL Cholesterol Study Results

Amgen Stock Falls After 'Boring' Q3 Beat

'Poor Quality' Amgen Earnings Beat Doesn't Impress These Two Wall Street Analysts

Amgen Stock Falls After 'Boring' Q3 Beat

'Poor Quality' Amgen Earnings Beat Doesn't Impress These Two Wall Street Analysts

Amgen's Repatha Results Not Good Enough For The Street

Esperion Surge May Be Fueled By Repatha Short Squeeze

Amgen's Repatha Results Not Good Enough For The Street

Esperion Surge May Be Fueled By Repatha Short Squeeze

Catalyst Alert: Amgen/Regeneron Patent Case Appeal Could Be Decided By April

Regeneron Falls As Court Grants Permanent Injunction For Infringement Of Amgen's Repatha Patents

Repatha Recent News

Barclays Says Acceleration For Amgen Could Be A Challenge

Amgen's Near-Term Catalyst Is Ph3 IVUS According To Goldman Sachs

Jury In Repatha Patent Case Ruled In Favor Of Amgen, Against Regeneron And Sanofi